How pharmacogenomics will impact the federal regulation of clinical trials and the new drug approval process. [electronic resource]
Producer: 20030516Description: 103-27 p. digitalISSN:- 1064-590X
- Clinical Trials as Topic -- legislation & jurisprudence
- Clinical Trials, Phase I as Topic
- Clinical Trials, Phase II as Topic
- Clinical Trials, Phase III as Topic
- Clinical Trials, Phase IV as Topic
- Drug Approval -- legislation & jurisprudence
- Drug Industry -- economics
- Pharmacogenetics -- legislation & jurisprudence
- United States
- United States Food and Drug Administration
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.